Market cap
$1.2b
End-of-day close multiplied by current shares on issue.
HGH · NZX
Heartland Group Holdings is an NZX-listed financials / banking and finance company. Its latest covered result is FY26, with HY22 - FY26 of source-backed result history on Annolyse.
Latest result
FY26, released 20 August 2026
| Metric | Value | Change |
|---|---|---|
| Revenue | $361.9m | ↑ +12.1% |
| Operating profit | $162.9m | — |
| NPAT | $93.2m | ↑ +140.2% |
| Operating cash flow | $120.8m | ↓ -82.1% |
| OCF / Operating profit % | 74.2% | — |
| ROE % | 7.0% | ↑ +3.8pp |
| DPS | 3.5c | ↑ +75.0% |
| PBT | $132.4m | ↑ +131.5% |
| FCF pre-lease | $117.3m | ↓ -82.5% |
| Total assets | $9.4b | ↑ +8.4% |
Source: latest published briefing (FY26, released 20 August 2026). Change compares against the prior equivalent period: FY25, released 21 August 2025.
Valuation
Trailing P/E, EV/EBITDA, price-to-book and price-to-free-cash-flow ratios combine the latest available close with filing data. They are comparative measures, not forecasts or recommendations.
The latest close and share count context for the market price.
Market cap
$1.2b
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
12.63x
Recent market cap compared with trailing earnings.
EPS
0.10
Recent filing-derived earnings per share.
PEG
0.09x
P/E compared with recent earnings growth.
EV/EBITDA
Not available
Not meaningful for this company type.
P/FCF
10.03x
Market cap compared with recent free cash flow.
P/B
0.88x
Market value compared with latest reported equity.
Yield and investment-company valuation where supported.
Dividend yield
5.6%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Daily closes use the full available width, with hover and touch values for each observation. Expand the chart to see more detail.
Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.
Filing-period markers only: EOD close on or before each release date divided by filing-derived trailing NPAT where both inputs verify.
Chat
Ask follow-up questions about Heartland Group Holdings's latest result and company history.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Financial history
The latest period is shown first.
| Metric | FY2612 MONTHS20 August 2026 | HY266 MONTHS26 February 2026 | FY2512 MONTHS21 August 2025 | HY256 MONTHS27 February 2025 | FY2412 MONTHS29 August 2024 | HY246 MONTHS27 February 2024 | FY2312 MONTHS29 August 2023 | HY236 MONTHS28 February 2023 | FY2212 MONTHS23 August 2022 | HY226 MONTHS22 February 2022 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $361.9m | $172.3m | $322.9m | $155.3m | $290.4m | $141.2m | $289.8m | $144.2m | $280.6m | $130.8m | Chart |
| Revenue growth % | 12.1%Outside range high revenue growth. 12.1%; 4-period range 0.2% to 11.7%. Revenue growth: 12.1%, above normal range; 4-period mean 6.6%, range 0.2%-11.7%. | 11.1%Outside range high revenue growth. 11.1%; 4-period range -2% to 10.2%. Revenue growth: 11.1%, above normal range; 4-period mean 6.8%, range -2.0%-10.2%. | 11.1% | 9.9% | 0.2% | -2.0% | 3.3% | 10.2% | 11.7% | 8.9% | Chart
|
| Operating profit | $162.9m | $77.9m | — | $57.2m | $151.3m | — | $161.7m | $80.7m | $163.9m | $73.5m | Chart |
| Operating profit margin % | 45.0% | 45.2% | — | 36.8% | 52.1% | — | 55.8% | 56.0% | 58.4% | 56.2% | Chart |
| PBT | $132.4m | $68.1m | $57.2m | $5.3m | $104.5m | $52.6m | $134m | $69m | $137m | $64.9m | Chart |
| PBT growth % | 131.5%Unprecedented high pbt growth. 131.5%; 4-period range -45.3% to 15.6%. PBT growth: 131.5%, unprecedented high; 4-period mean -13.5%, range -45.3%-15.6%. | — | -45.3%Outside range low pbt growth. -45.3%; 3-period range -22% to 15.6%. PBT growth: -45.3%, below normal range; 3-period mean -2.9%, range -22.0%-15.6%. | -89.9%Outside range low pbt growth. -89.9%; 3-period range -23.8% to 8.9%. PBT growth: -89.9%, below normal range; 3-period mean -2.9%, range -23.8%-8.9%. | -22.0% | -23.8% | -2.2% | 6.3% | 15.6% | 8.9% | Chart
|
| NPAT | $93.2m | $48.8m | $38.8m | $3.6m | $74.5m | $37.6m | $95.9m | $48.7m | $95.1m | $47.5m | Chart |
| NPAT growth % | 140.2%Unprecedented high npat growth. 140.2%; 4-period range -47.9% to 9.3%. NPAT growth: 140.2%, unprecedented high; 4-period mean -15.0%, range -47.9%-9.3%. | n/mUnprecedented high npat growth. n/m; 4-period range -90.4% to 7.7%. NPAT growth: n/m, unprecedented high; 4-period mean -25.7%, range -90.4%-7.7%. | -47.9%Outside range low npat growth. -47.9%; 3-period range -22.3% to 9.3%. NPAT growth: -47.9%, below normal range; 3-period mean -4.1%, range -22.3%-9.3%. | -90.4%Outside range low npat growth. -90.4%; 3-period range -22.8% to 7.7%. NPAT growth: -90.4%, below normal range; 3-period mean -4.2%, range -22.8%-7.7%. | -22.3% | -22.8% | 0.8% | 2.5% | 9.3% | 7.7% | Chart
|
| Operating cash flow | $120.8m | $299.5m | $673.2m | $236.6m | $928.4m | -$8.8m | $42.7m | $262.2m | -$262.3m | -$142.3m | Chart |
| OCF / Operating profit % | 74.2% | 384.7% | — | 413.5% | 613.7% | — | 26.4% | 324.8% | -160.1% | -193.6% | Chart |
| FCF pre-lease | $117.3m | — | $668.8m | — | $900.3m | -$25.5m | — | $254.4m | -$272.1m | -$150.9m | Chart |
| DPS | 3.5c | 3.5c | 2.0c | 2.0c | 3.0c | 4.0c | 6.0c | 5.5c | 5.5c | 5.5c | Chart |
| Payout ratio vs NPAT % | — | 67.3%Outside range low payout ratio versus npat. 67.3%; 4-period range 68.1% to 500%. Payout ratio versus NPAT: 67.3%, below normal range; 4-period mean 179.7%, range 68.1%-500.0%. | 96.6%Outside range high payout ratio versus npat. 96.6%; 3-period range 68.2% to 82.4%. Payout ratio versus NPAT: 96.6%, above normal range; 3-period mean 73.9%, range 68.2%-82.4%. | 500.0%Outside range high payout ratio versus npat. 500%; 3-period range 68.1% to 75.5%. Payout ratio versus NPAT: 500.0%, above normal range; 3-period mean 73.0%, range 68.1%-75.5%. | 71.1% | 75.5% | 82.4% | 75.3% | 68.2% | 68.1% | Chart
|
| Annual payout ratio vs EPS % | — | — | 96.6% | — | 71.1% | — | 82.4% | — | 68.2% | — | Chart |
| ROE % | 7.0% | 3.8%Outside range high roe. 7.8%; 4-period range 0.3% to 6.1%. ROE: 7.8%, above normal range; 4-period mean 3.7%, range 0.3%-6.1%. | 3.2%Outside range low roe. 3.2%; 3-period range 6% to 11.8%. ROE: 3.2%, below normal range; 3-period mean 9.0%, range 6.0%-11.8%. | 0.3%Outside range low roe. 0.3%; 3-period range 3.7% to 6.1%. ROE: 0.3%, below normal range; 3-period mean 4.9%, range 3.7%-6.1%. | 6.0% | 3.7% | 9.3% | 4.8% | 11.8% | 6.1% | Chart
|
| Debtor days | — | — | — | — | 0 | — | 1 | — | n/m | — | Chart |
| Total assets | $9.4b | $8.8b | $8.6b | $8.8b | $9.3b | $7.9b | $7.7b | $7.4b | $7.1b | $6b | Chart |
Reference: annolyse.ai/companies/hgh
Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.
These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.
Reported revenue across covered periods.
Like-period revenue growth where comparable.
Company-specific earnings measure where disclosed.
EBITDA-equivalent margin where revenue and earnings are source-backed.
Statutory profit after tax.
Cash generated from operations.
Additional filing-backed metrics for this company. Each point links to the relevant published briefing.
Cash conversion against earnings.
Operating cash flow less capex before leases.
Return on equity.
Dividend per share declared for the period.
Dividend payout against statutory NPAT.
Receivables days where the working-capital inputs are source-backed.
The setup & the reality
The latest result is checked against what the prior briefing said to watch.
Historical setup
Previous analysisHY26Result releasedAnnolyse analysis published
From NPAT rebuilt to NZ$48.8m as the NZ lending reset rolls off
No quantitative FY26 NPAT target is supplied in the release excerpts beyond underlying ROE of "at least 7%", which HY26 already meets at 7.8%. The shape context is unusual: HY25 contributed only 9.3% of FY25 NPAT (NZ$3.6m of NZ$38.8m), reflecting the first-half reset rather than a structural seasonality. With HY26 underlying NPAT of NZ$46.1m almost matching FY25 underlying NPAT of NZ$46.9m in a single half, the implicit FY26 trajectory looks materially ahead of FY25 underlying if the second half holds.
The release does not disclose a numeric FY26 NPAT or NOI target, so this briefing cannot mark the result against a stated dollar number; the read is anchored to the company's own ≥7% underlying ROE guide and FY25 baseline.
Open questions
This briefing cannot assess credit quality or impairment trajectory in detail, since segment-level provisioning and arrears data are not supplied in the structured extraction.
Primary issuer documents used for the FY26 briefing. Document labels are preserved from the publication record; Annolyse does not relabel every financial report as an annual report.
Heartland FY2026 - Results Announcement Template
FY26 / results announcementHeartland FY2026 Annual Report: source-curated FY26 column
FY26 / financial reportHeartland FY2026 Annual Report: source-curated FY25 column
FY25 / financial reportPeer context
These companies share a broad sector but may not be direct peers. Compare them only where the underlying measures are genuinely comparable.
Archive
The full chronological archive contains every published result briefing.
FY26 · Released 20 August 2026
Lower impaired-asset expense and stronger pre-impairment profit supported the statutory earnings increase.
HY26 · Released 26 February 2026
The n/m headline NPAT lift is recovery from a depressed comparable; underlying NPAT of NZ$46.1m and ROE of 7.8% set the cleaner read.
FY25 · Released 21 August 2025
Revenue grew solidly but a surge in impairments, acquisition-related costs, and a portfolio reset crushed statutory earnings, leaving underlying NPAT
HY25 · Released 27 February 2025
Reported NPAT of NZ$3.6m versus underlying NZ$10.7m and a 500% NPAT payout ratio leave the dividend reliant on retained earnings, not current profit.
FY24 · Released 29 August 2024
Revenue growth of just 0.2% left no buffer when provisions surged, driving a 22.0% PBT decline and compressing ROE to 6.0% from 9.3%.
HY24 · Released 27 February 2024
Net operating income contracted despite 4.2% receivables growth, pointing to material net interest margin compression ahead of Challenger integration.
Get the next Heartland Group Holdings result briefing and five-year history updates by email.